Display options
Share it on

Adv Biomed Res. 2015 May 11;4:93. doi: 10.4103/2277-9175.156657. eCollection 2015.

The effect of time and temperature on viability and performance of Langerhans islets separated from Balb/c mouse after death.

Advanced biomedical research

Rostam Ghorbani, Cyrus Jalili, Mohammad Reza Salahshoor, Maryam Shiasi

Affiliations

  1. Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  2. Department of Anatomy, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 26015919 PMCID: PMC4434490 DOI: 10.4103/2277-9175.156657

Abstract

BACKGROUND: Tissue transplantation plays a pivotal role in the treatment of diseases. Pancreatic beta cell transplantation is the best way to obtain normal blood glucose in patients with diabetes type 1. However, it is not clear how long endocrine pancreas cells can be used for transplantation after the donor's death. The present study was conducted to analyze the performance and viability of pancreatic islet cells after death.

MATERIALS AND METHODS: Pancreas was separated from Balb/c mice at different times (0, 1, 4, 6, 12, and 24 h after death) at temperatures of 4°C and 23°C, and was cultured in Roswell_Park_Memorial_Institute (RPMI) 1640. Insulin shock, MTT assay, aldehyde fuchsin staining, dithizone staining, and florescence microscopy methods were applied to analyze the performance of beta cells, cell viability, islets' diagnosis, islet cells' diagnosis, and viable and necrotic cells diagnosis, respectively.

RESULTS: Islets of Langerhans and beta cells were diagnosed. By increasing the temperature and time, the viability and performance of beta cells decreased significantly (P < 0.05).

CONCLUSION: The best condition for keeping the islets of Langerhans in terms of viability and performance is 4 h after death at temperature of 4°C.

Keywords: Cell viability; Langerhans islets; performance; temperature; time

References

  1. Diabetes. 2003 Dec;52(12):2935-42 - PubMed
  2. Diabetes. 2013 May;62(5):1646-55 - PubMed
  3. Toxicol Pathol. 2014 Jan;42(1):45-8 - PubMed
  4. Pancreas. 2013 Mar;42(2):317-21 - PubMed
  5. BMC Complement Altern Med. 2013 Aug 19;13:212 - PubMed
  6. Res Pharm Sci. 2014 Sep-Oct;9(5):351-8 - PubMed
  7. J Mol Endocrinol. 1996 Feb;16(1):1-8 - PubMed
  8. Liver Transpl. 2013 Mar;19(3):328-35 - PubMed
  9. Gastrointest Endosc. 2013 May;77(5):784-92 - PubMed
  10. Transplantation. 2011 Mar 15;91(5):508-14 - PubMed
  11. Ann Surg. 2003 Jun;237(6):741-9; discussion 749-50 - PubMed
  12. Leg Med (Tokyo). 2004 Mar;6(1):25-31 - PubMed
  13. Diabetologia. 2013 Mar;56(3):508-19 - PubMed
  14. Cardiovasc Intervent Radiol. 1999 Jul-Aug;22(4):342-4 - PubMed
  15. Cell Transplant. 2013;22(7):1101-11 - PubMed
  16. Diabetes. 1967 Jan;16(1):35-9 - PubMed
  17. Cell Mol Biol Lett. 2011 Mar;16(1):101-13 - PubMed
  18. Transplant Proc. 2001 Feb-Mar;33(1-2):1707-8 - PubMed
  19. Diabetologia. 1976 May;12(2):115-21 - PubMed
  20. J Assoc Res Otolaryngol. 2007 Jun;8(2):194-204 - PubMed
  21. J Clin Endocrinol Metab. 2013 Apr;98(4):E727-31 - PubMed
  22. Physiol Res. 2004;53(3):327-33 - PubMed
  23. Islets. 2013 May-Jun;5(3):111-5 - PubMed
  24. Am J Physiol. 1982 May;242(5):C382-7 - PubMed
  25. Ann Surg. 2000 Feb;231(2):269-75 - PubMed
  26. World J Gastroenterol. 2009 Sep 7;15(33):4163-9 - PubMed
  27. Cytotechnology. 2005 Jun;48(1-3):75-8 - PubMed
  28. Fitoterapia. 2013 Jun;87:84-8 - PubMed
  29. Biosci Biotechnol Biochem. 2003 Nov;67(11):2396-401 - PubMed

Publication Types